WASHINGTON — Two powerful Senate lawmakers laid out an unexpectedly ambitious plan to lower the price of prescription drugs Thursday.
It came as part of a highly anticipated health care package from Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), the duo that helms the Senate health committee that is widely respected for bipartisan health-policy work.
As recently as Wednesday, aides and lobbyists said the package would be more focused on surprise medical bills than on drug pricing; they expected any policies aimed at the latter issue to be small, targeted, and uncontroversial.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect